Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia-Reference-Cited by-同舟云学术

Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia

Published:2010-02 Issue:1 Volume:16 Page:202-205
ISSN:1356-1294
Container-title:Journal of Evaluation in Clinical Practice
language:en
Short-container-title:

Author:

Lee I-Te,Liau Yi-Ju,Lee Wen-Jane,Huang Chien-Ning,Sheu Wayne H-H.

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2753.2009.01134.x/fullpdf

Reference17 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research group;New England Journal of Medicine,1993

2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study;Ohkubo;Diabetes Research and Clinical Practice,1995

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study Group;Lancet,1998

4. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes;Pickup;Diabetes Care,2002

5. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections;King;Diabetes Care,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous Insulin Therapy to Prevent Post-Transplant Diabetes Mellitus: A Randomized Controlled Trial;Kidney Medicine;2024-08

2. Automated Insulin Delivery Technology in the Hospital: Update on Safety and Efficacy Data;Endocrine Practice;2024-07

3. Hybrid Closed-Loop Insulin Pump Technology Can Be Safely Used in the Inpatient Setting;Endocrine Practice;2023-01

4. Efficacy of Hybrid Closed-Loop Insulin Delivery System in a Hospital Setting: A Case Series;AACE Clinical Case Reports;2021-01

5. A guide for the pharmacist's role in insulin pump management during transitions of care;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2020-11-12